The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Ribosomal S6 Kinase Signaling and the Control of Translation
Abstract
The highly homologous 40S ribosomal protein S6 kinases (S6K1 and S6K2) play a key role in the regulation of cell growth by controlling the biosynthesis of translational components which make up the protein synthetic apparatus, most notably ribosomal proteins. In the case of S6K1, at least eight phosphorylation sites are believed to mediate kinase activation in a hierarchical fashion. Activation is initiated by phosphatidylinositide-3OH kinase (PI3K)-mediated phosphorylation of key residues in the carboxy-terminus of the kinase, allowing phosphorylation of a critical residue residing in the activation loop of the catalytic domain by phosphoinositide-dependent kinase 1 (PDK1). The kinases responsible for phosphorylating the carboxy-terminal sites have yet to be identified. Additionally, S6 kinases are under the control of the PI3K relative, mammalian Target Of Rapamycin (mTOR), which may serve an additional function as a checkpoint for amino acid availability. In this review we set out to discuss the present state of knowledge regarding upstream signaling components which have been implicated in the control of S6K1 activation and the role of the kinase in controlling cell growth through regulating ribosome biogenesis at the translational level.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mTOR can also phosphorylate eIF4G, the ribosomal S6 kinases (RS6K) such as p70S6K which phosphorylate eIF4B, enhancing its interaction with eIF3 and stimulate protein synthesis [75–77] (Fig. 1).”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [77]
Citations
Cites
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Phosphorylation and Activation of p70 s6k by PDK1
Pullen, N., Dennis, P. B., Andjelkovic, M., Dufner, A., Kozma, S. C., Hemmings, B. A., & Thomas, G. (1998) · Science · doi:10.1126/science.279.5351.707 · Cited by 826
Self-citationHajduch, E., Alessi, D. R., Hemmings, B. A., & Hundal, H. S. (1998) · Diabetes · doi:10.2337/diabetes.47.7.1006 · Cited by 335
Flagged first, then by citations
Research works printed but not linked: 89
- Akimoto, 1998, Atypical protein kinase C lambda binds and regulates p70 S6 kinase, Biochem. J., 335, 417, 10.1042/bj3350417 · DOI
- Akimoto, 1996, EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase, EMBO J., 15, 788, 10.1002/j.1460-2075.1996.tb00414.x · DOI
- Alessi, 1996, Mechanism of activation of protein kinase B by insulin and IGF-1, EMBO J., 23, 6541, 10.1002/j.1460-2075.1996.tb01045.x · DOI
- Alessi, 1997, 3-Phosphoinositide-dependent protein kinase-1 (PDK1): Structural and functional homology with the Drosophila DSTPK61 kinase, Curr. Biol., 7, 776, 10.1016/S0960-9822(06)00336-8 · DOI
- Alessi, 1997, Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha, Curr. Biol., 7, 261, 10.1016/S0960-9822(06)00122-9 · DOI
- Alessi, 1998, 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro, Curr. Biol., 8, 69, 10.1016/S0960-9822(98)70037-5 · DOI
- Andjelkovic, 1999, Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase, Mol. Cell. Biol., 19, 5061, 10.1128/MCB.19.7.5061 · DOI
- Ballou, 1988, Protein phosphatase 2A inactivates the mitogen-stimulated S6 kinase from Swiss mouse 3T3 cells, J. Biol. Chem., 263, 1188, 10.1016/S0021-9258(19)57284-2 · DOI
- Banerjee, 1990, Molecular structure of a major insulin/mitogen-activated 70 kDa S6 protein kinase, Proc. Natl. Acad. Sci. USA, 87, 8550, 10.1073/pnas.87.21.8550 · DOI
- Begum, 1996, cAMP counter-regulates insulin-mediated protein phosphatase-2A inactivation in rat skeletal muscle cells, J. Biol. Chem., 271, 31166, 10.1074/jbc.271.49.31166 · DOI
- Blommaart, 1995, Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes, J. Biol. Chem., 270, 2320, 10.1074/jbc.270.5.2320 · DOI · Paper page
- Brennan, 1999, p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes, Mol. Cell. Biol., 19, 4729, 10.1128/MCB.19.7.4729 · DOI
- Brown, 1994, A mammalian protein targeted by G1-arresting rapamycin–receptor complex, Nature, 369, 756, 10.1038/369756a0 · DOI · Paper page
- Burgering, 1995, Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction, Nature, 376, 599, 10.1038/376599a0 · DOI
- Burnett, 1998, RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1, Proc. Natl. Acad. Sci. USA, 95, 1432, 10.1073/pnas.95.4.1432 · DOI
- Burnett, 1998, Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton, Proc. Natl. Acad. Sci. USA, 95, 8351, 10.1073/pnas.95.14.8351 · DOI
- Calvo, 1992, Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin, Proc. Natl. Acad. Sci. USA, 89, 7571, 10.1073/pnas.89.16.7571 · DOI
- Cheatham, 1994, Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation, Mol. Cell. Biol., 14, 4902, 10.1128/MCB.14.7.4902 · DOI
- Cheatham, 1995, Structural and functional analysis of pp70s6k, Proc. Natl. Acad. Sci. USA, 92, 11696, 10.1073/pnas.92.25.11696 · DOI
- Chen, 1998, Alpha 4 associates with protein phosphatases 2A, 4 and 6, Biochem. Biophys. Res. Commun., 247, 827, 10.1006/bbrc.1998.8792 · DOI
- Chou, 1998, Regulation of protein kinase C zeta by PI 3-kinase and PDK-1, Curr. Biol., 8, 1069, 10.1016/S0960-9822(98)70444-0 · DOI
- Chung, 1994, PDGF- and insulin-dependent pp70s6k activation mediated by phosphatidylinositol-3-OH kinase, Nature, 370, 71, 10.1038/370071a0 · DOI
- Chung, 1992, Rapamycin–FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases, Cell, 69, 1227, 10.1016/0092-8674(92)90643-Q · DOI
- Conlon, 1999, Size control in animal development, Cell, 96, 235, 10.1016/S0092-8674(00)80563-2 · DOI
- Conus, 1998, Differential regulation by calcium reveals distinct signaling requirements for the activation of Akt and p70s6k, J. Biol. Chem., 273, 4776, 10.1074/jbc.273.8.4776 · DOI
- Currie, 1999, Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1, Biochem. J., 337, 575, 10.1042/0264-6021:3370575 · DOI
- Dennis, 1999, Target of rapamycin (TOR): Balancing the opposing forces of protein synthesis and degradation, Curr. Opin. Genet. Dev., 9, 49, 10.1016/S0959-437X(99)80007-0 · DOI
- Dennis, 1996, The principal rapamycin-sensitive p70s6k phosphorylation sites T229 and T389 are differentially regulated by rapamycin-insensitive kinase–kinases, Mol. Cell. Biol., 16, 6242, 10.1128/MCB.16.11.6242 · DOI
- Dennis, 1998, Phosphorylation sites in the autoinhibitory domain participate in p70s6k activation loop phosphorylation, J. Biol. Chem., 273, 14845, 10.1074/jbc.273.24.14845 · DOI
- Di Como, 1996, Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases, Genes Dev., 10, 1904, 10.1101/gad.10.15.1904 · DOI
- Dufner, 1999, Protein kinase B localization and activation differentially affect S6 kinase 1 activity and eukaryotic translation initiation factor 4E-binding protein 1 phosphorylation, Mol. Cell. Biol., 19, 4525, 10.1128/MCB.19.6.4525 · DOI
- Dunn, 1994, Autophagy and related mechanisms of lysosome-mediated protein degradation, Trends Cell Biol., 4, 139, 10.1016/0962-8924(94)90069-8 · DOI
- Edelmann, 1996, Cell cycle regulation of p70 S6 kinase and p42/p44 mitogen-activated protein kinases in Swiss mouse 3T3 fibroblasts, J. Biol. Chem., 271, 963, 10.1074/jbc.271.2.963 · DOI
- Ferrari, 1992, Activation of p70s6k is associated with phosphorylation of four clustered sites displaying Ser/Thr-Pro motifs, Proc. Natl. Acad. Sci. USA, 89, 7282, 10.1073/pnas.89.15.7282 · DOI
- Ferrari, 1993, The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sites, J. Biol. Chem., 268, 16091, 10.1016/S0021-9258(19)85389-9 · DOI
- Flotow, 1992, Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver, J. Biol. Chem., 267, 3074, 10.1016/S0021-9258(19)50696-2 · DOI
- Franco, 1990, Hormonally inducible phosphorylation of a nuclear pool of ribosomal protein S6, J. Biol. Chem., 265, 4321, 10.1016/S0021-9258(19)39566-3 · DOI
- Garcia-Paramio, 1998, The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation, Biochem. J., 333, 631, 10.1042/bj3330631 · DOI
- Grove, 1991, Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini, Mol. Cell. Biol., 11, 5541, 10.1128/MCB.11.11.5541 · DOI
- Han, 1995, Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites, J. Biol. Chem., 36, 21396, 10.1074/jbc.270.36.21396 · DOI
- Hara, 1998, Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism, J. Biol. Chem., 273, 14484, 10.1074/jbc.273.23.14484 · DOI
- Iiboshi, 1999, Amino acid-dependent control of p70(s6k). Involvement of tRNA aminoacylation in the regulation, J. Biol. Chem., 274, 1092, 10.1074/jbc.274.2.1092 · DOI
- Jefferies, 1997, Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k, EMBO J., 12, 3693, 10.1093/emboj/16.12.3693 · DOI · Paper page
- Jenö, 1988, Identification and characterization of a mitogenic-activated S6 kinase, Proc. Natl. Acad. Sci. USA, 85, 406, 10.1073/pnas.85.2.406 · DOI
- Jiang, 1999, Tor proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast, EMBO J., 18, 2782, 10.1093/emboj/18.10.2782 · DOI
- Kotani, 1998, Requirement of atypical protein kinase c lambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes, Mol. Cell. Biol., 18, 6971, 10.1128/MCB.18.12.6971 · DOI
- Kozma, 1990, Cloning of the mitogen-activated S6 kinase from rat liver reveals an enzyme of the second messenger subfamily, Proc. Natl. Acad. Sci. USA, 87, 7365, 10.1073/pnas.87.19.7365 · DOI
- Kunz, 1993, Target of rapamycin in yeast, TOR2 is an essential phosphatidylinosito kinase homolog required for G1 progression, Cell, 73, 585, 10.1016/0092-8674(93)90144-F · DOI
- Kuo, 1992, Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase, Nature, 358, 70, 10.1038/358070a0 · DOI
- Lane, 1993, p70s6k function is essential for G1 progression, Nature, 363, 170, 10.1038/363170a0 · DOI
- Le Good, 1998, Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1, Science, 281, 2042, 10.1126/science.281.5385.2042 · DOI
- Leibiger, 1998, Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways, Mol. Cell, 1, 933, 10.1016/S1097-2765(00)80093-3 · DOI
- Ming, 1994, Activation of p70/p85 S6 kinase by a pathway independent of p21ras, Nature, 371, 426, 10.1038/371426a0 · DOI
- Montagne, 1999, Drosophila S6 kinase: A regulator of cell size, Science, 285, 2126, 10.1126/science.285.5436.2126 · DOI
- Moser, 1997, Dual requirement for a newly identified phosphorylation site in p70s6k, Mol. Cell. Biol., 17, 5648, 10.1128/MCB.17.9.5648 · DOI
- Mukhopadhayay, 1992, An array of insulin-activated, proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase, J. Biol. Chem., 267, 3325, 10.1016/S0021-9258(19)50735-9 · DOI
- Murata, 1997, B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A, Proc. Natl. Acad. Sci. USA, 94, 10624, 10.1073/pnas.94.20.10624 · DOI
- Nakanishi, 1993, Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate, J. Biol. Chem., 268, 13, 10.1016/S0021-9258(18)54107-7 · DOI
- Nakanishi, 1997, Neurabin: A novel neural tissue-specific actin filament-binding protein involved in neurite formation, J. Cell Biol., 139, 951, 10.1083/jcb.139.4.951 · DOI
- Nanahoshi, 1998, Regulation of protein phosphatase 2A catalytic activity by alpha4 and its yeast homolog Tap42, Biochem. Biophys. Res. Commun., 251, 520, 10.1006/bbrc.1998.9493 · DOI
- Nygard, 1990, Translational dynamics. Interactions between the translational factors, tRNA and ribosomes during eukaryotic protein synthesis, Eur. J. Biochem., 191, 1, 10.1111/j.1432-1033.1990.tb19087.x · DOI
- Olivier, 1988, Differential regulation of S6 phosphorylation by insulin and epidermal growth factor in Swiss mouse 3T3 cells: Insulin activation of type 1 phosphatase, Proc. Natl. Acad. Sci. USA, 85, 4720, 10.1073/pnas.85.13.4720 · DOI
- Papst, 1998, Cdc2-cyclin B phosphorylates p70 S6 kinase on Ser411 at mitosis, J. Biol. Chem., 273, 15077, 10.1074/jbc.273.24.15077 · DOI
- Pearson, 1995, The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain, EMBO J., 21, 5279, 10.1002/j.1460-2075.1995.tb00212.x · DOI · Paper page
- Pellizzoni, 1997, Cellular nucleic acid binding protein binds a conserved region of the 5′ UTR of Xenopus laevis ribosomal protein mRNAs, J. Mol. Biol., 267, 264, 10.1006/jmbi.1996.0888 · DOI
- Pellizzoni, 1998, Involvement of the Xenopus laevis Ro60 autoantigen in the alternative interaction of La and CNBP proteins with the 5′UTR of L4 ribosomal protein mRNA, J. Mol. Biol., 281, 593, 10.1006/jmbi.1998.1961 · DOI
- Peterson, 1999, Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12–rapamycin-associated protein, Proc. Natl. Acad. Sci. USA, 96, 4438, 10.1073/pnas.96.8.4438 · DOI
- Peterson, 1998, Translation control: Connecting mitogens and the ribosome, Curr. Biol., 8, R248, 10.1016/S0960-9822(98)70152-6 · DOI
- Price, 1992, Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase, Science, 257, 973, 10.1126/science.1380182 · DOI
- Price, 1991, Insulin-activated kinases phosphorylate a pseudo-substrate inhibitor of the p70 S6 kinase, J. Biol. Chem., 266, 16281, 10.1016/S0021-9258(18)55291-1 · DOI
- Pullen, 1997, The modular phosphorylation and activation of p70s6k, Fed. Eur. Biochem. Soc. Lett., 410, 78, 10.1016/S0014-5793(97)00323-2 · DOI
- Reinhard, 1994, Nuclear localization of p85s6k: Functional requirement for entry into S phase, EMBO J., 13, 1557, 10.1002/j.1460-2075.1994.tb06418.x · DOI
- Reinhard, 1992, A single gene encodes two isoforms of the p70 S6 kinase: Activation upon mitogenic stimulation, Proc. Natl. Acad. Sci. USA, 89, 4052, 10.1073/pnas.89.9.4052 · DOI
- Romanelli, 1999, p70 S6 kinase is regulated by protein kinase C zeta and participates in a phosphoinositide 3-kinase-regulated signaling complex, Mol. Cell. Biol., 19, 2921, 10.1128/MCB.19.4.2921 · DOI
- Sabatini, 1994, RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs, Cell, 78, 35, 10.1016/0092-8674(94)90570-3 · DOI · Paper page
- Shigemitsu, 1999, Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells, J. Biol. Chem., 274, 1058, 10.1074/jbc.274.2.1058 · DOI
- Shima, 1998, Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase, EMBO J., 17, 6649, 10.1093/emboj/17.22.6649 · DOI
- Standaert, 1997, Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport, J. Biol. Chem., 272, 30075, 10.1074/jbc.272.48.30075 · DOI
- Stephens, 1998, Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B, Science, 279, 710, 10.1126/science.279.5351.710 · DOI
- Stewart, 1994, Mitogenesis and protein synthesis: A role for ribosomal protein S6 phosphorylation, BioEssays, 16, 1, 10.1002/bies.950161107 · DOI
- Stokoe, 1997, Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B, Science, 277, 567, 10.1126/science.277.5325.567 · DOI
- Su, 1998, Size control: Cell proliferation does not equal growth, Curr. Biol., 8, R687, 10.1016/S0960-9822(98)70436-1 · DOI
- Thomas, 1997, TOR signaling and control of cell growth, Curr. Opin. Cell Biol., 9, 782, 10.1016/S0955-0674(97)80078-6 · DOI · Paper page
- Von Manteuffel, 1997, The insulin-induced signaling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k, Mol. Cell. Biol., 17, 5426, 10.1128/MCB.17.9.5426 · DOI
- Wang, 1998, Amino acid availability regulates p70 S6 kinase and multiple translation factors, Biochem. J., 334, 261, 10.1042/bj3340261 · DOI
- Weng, 1995, Multiple independent inputs are required for activation of the p70 S6 kinase, Mol. Cell. Biol., 15, 2333, 10.1128/MCB.15.5.2333 · DOI
- Weng, 1998, Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies, J. Biol. Chem., 273, 16621, 10.1074/jbc.273.26.16621 · DOI
- Westphal, 1999, Identification of kinase–phosphatase signaling modules composed of p70 S6 kinase–protein phosphatase 2A (PP2A) and p21-activated kinase–PP2A, J. Biol. Chem., 274, 687, 10.1074/jbc.274.2.687 · DOI
- Ziegler, 1999, Rapamycin-sensitive phosphorylation of PKC on a carboxy-terminal site by an atypical PKC complex, Curr. Biol., 9, 522, 10.1016/S0960-9822(99)80236-X · DOI
Cited by
Sorted by citations
Items 301–400 of 622
Wang, T., Wagner, A., Gehwolf, R., Yan, W.-J., Passini, F. S., Thien, C., Weissenbacher, N., Lin, Z., Lehner, C., Teng, H.-J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe5738 · Cited by 46
“S6K, a downstream target of mammalian target of rapamycin (mTOR), is a key regulator of protein synthesis and is required for cell cycle progression, cell differentiation, and growth (33).”
BackgroundD'Abronzo, L. S., Bose, S., Crapuchettes, M., Beggs, R. E., Vinall, R. L., Tepper, C. G., Siddiqui, S., Mudryj, M. M., Melgoza, F. U., Durbin-Johnson, B. P., et al. (2017) · Oncogene · doi:10.1038/onc.2017.233 · Cited by 45
“Both p70S6 kinase (27, 28) and Akt (29, 30) requires phosphorylation by both mTOR and PDK1 for full activation.”
BackgroundJiang, X., Zhu, S., Panetti, T. S., & Bromberg, M. E. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-12-0722 · Cited by 49
Deguil, J., Jailloux, D., Page, G., Fauconneau, B., Houéto, J., Philippe, M., Jm, M., & Pain, S. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21318 · Cited by 42
“The kinase responsible for this is mammalian target of rapamycin (mTOR; Schmelzle and Hall, 2000; Raught et al., 2001), which can also phosphorylate ribosomal p70S6 kinase (p70S6K), a stimulator of protein synthesis (Dufner and Thomas, 1999).”
BackgroundSeo, J., Lee, J.-H., Kim, N., Her, E., Chang, S.-H., Ko, N.-Y., Yoo, Y., Kim, J.-W., Seo, D., Han, J.-W., et al. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.01.008 · Cited by 46
Refeeding and insulin regulate S6K1 activity in chicken skeletal muscles.
Bigot, K., Taouis, M., & Tesseraud, S. (2003) · Journal of NutriLife · doi:10.1093/jn/133.2.369 · Cited by 46
Werner, C. T., Stefanik, M. T., Milovanovic, M., Caccamise, A. J., & Wolf, M. E. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2412-17.2018 · Cited by 46
“We also evaluated s6, which directly increases translation initiation when phosphorylated (Dufner and Thomas, 1999).”
BackgroundSun, R., Zhang, S., Hu, W., Lü, X. Q., Lou, N., Zhen-de, Y., Chen, S., Zhang, X., & Yang, H. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00344.2015 · Cited by 51
“p-Akt promotes phosphorylation and 106 activation of S6 kinase (S6) (14, 26), which is a downstream signaling molecule in the 107 Akt signaling pathway.”
Li, Q., Fu, G.-B., Zheng, J.-T., He, J., Niu, X.-B., Chen, Q.-D., Yin, Y., Qian, X., Xu, Q., Wang, M., et al. (2013) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamcr.2013.09.018 · Cited by 45
Tuberin activates the proapoptotic molecule BAD
Freilinger, A., Rosner, M., Krupitza, G., Nishino, M., Lübec, G., Korsmeyer, S. J., & Hengstschläger, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209660 · Cited by 44
“…is phosphorylated by several kinases, including AKT, which suppresses its activity (Li et al., 2003; Pan et al., 2004; Astrinidis and Henske, 2005). mTOR phosphorylates p70S6K (p70 ribosomal protein S6 kinase) on Thr389, which correlates with the activation of p70S6K (Dufner and Thomas, 1999).”
BackgroundAn essential role for protein synthesis in oncogenic cellular transformation
Bader, A. G., & Vogt, P. K. (2004) · Oncogene · doi:10.1038/sj.onc.1207550 · Cited by 43
“The latter function is mediated by TOR-dependent phosphorylation of p70 S6 kinase (S6K) and of 4E-binding proteins (4E-BPs) (Sonenberg and Gingras, 1998; Dufner and Thomas, 1999; Gingras et al., 2001; Gingras et al., 2004).”
BackgroundTSH signaling and cell survival in 3T3-L1 preadipocytes
Bell, A., Gagnon, A., Dods, P., Papineau, D., Tiberi, M., & Sorisky, A. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00058.2002 · Cited by 45
“p70 S6K is implicated in the control of transcription and translation, and its phosphorylation leads to a complex sequence of conformational changes that activate the enzyme (11).”
BackgroundMethodGuizzetti, M., & Costa, L. G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00942.x · Cited by 45
“The 70-kDa ribosomal S6 kinase (p70S6K) is an ubiquitously expressed serine/threonine protein kinase that phosphorylates the 40S ribosomal protein S6 in response to mitogen stimulation (Dufner and Thomas 1999).”
BackgroundAkt is negatively regulated by Hippo signaling for growth inhibition in Drosophila
Ye, X., Deng, Y., & Lai, Z.-C. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.06.014 · Cited by 43
“TOR and PDK1 also activate ribosomal S6 kinase (S6K), thereby controlling the activity of protein translation machinery (Dufner and Thomas, 1999).”
BackgroundExploiting p70 S6 kinase as a target for ovarian cancer
Ip, C. K. M., & Wong, A. S. T. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.684680 · Cited by 46
“propose that mitogen-activated protein kinase (MAPK) signaling is required for full p70 activation [20] as the proline-flanked phosphorylation sites in the autoinhibitory domain of p70 are of consensus sequences similar to those of MAPKs and that phosphorylation at the autoinhibitory domain is an early step required f…”
BackgroundEtscheid, M., Beer, N., & Dodt, J. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.007 · Cited by 44
Hartmann, B., Schmid, G., Graeb, C., Bruns, C., Fischereder, M., Jauch, K., Heeschen, C., & Guba, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00731.x · Cited by 44
Activation of the p70 S6 kinase by all-trans-retinoic acid in acute promyelocytic leukemia cells
Lal, L., Li, Y., Smith, J., Sassano, A., Shahab Uddin, M. S., Parmar, S., Tallman, M. S., Minucci, S., Hay, N., & Platanias, L. C. (2004) · Blood · doi:10.1182/blood-2004-06-2078 · Cited by 43
“The p70 S6 kinase was originally identified as a kinase that regulates serine phosphorylation of the 40S ribosomal S6 protein (rpS6) (32-36).”
BackgroundTu, X. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00178-2 · Cited by 38
Belletti, B., Prisco, M., Morrione, A., Valentinis, B., Navarro, M., & Baserga, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010509200 · Cited by 44
Li, W., & Sumpio, B. E. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00382.2004 · Cited by 46
“To determine whether cyclic strain induces S6K activation in ECs exposed to cyclic strain, we assessed for phosphorylation of S6K in time-course experiments using phospho-specific antibodies (15).”
MethodLi, W., Chen, Q., Mills, I., & Sumpio, B. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10230 · Cited by 43
“…(Ferrari et al., 1991; Flotow and Thomas, 1992; Guay et al., 1997; Huot et al., 1997; Jefferies et al., 1997; Larsen et al., 1997; Kultz, 1998; Peterson and Schreiber, 1998; Dufner and Thomas, 1999; Li et al., 1999; Duzgun et al., 2000; Kito et al., 2000; Azuma et al., 2001; Li et al., 2001).”
El‐Darawish, Y., Li, W., Yamanishi, K., Pencheva-Demireva, M., Oka, N., Yamanishi, H., Matsuyama, T., Tanaka, Y., Minato, N., & Okamura, H. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1hi1017-396rr · Cited by 44
Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin
Du, W., Gerald, D., Perruzzi, C. A., Rodriguez‐Waitkus, P., Enayati, L., Krishnan, B., Edmonds, J., Hochman, M. L., Lev, D. C., & Phung, T. L. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.98 · Cited by 41
Hsieh, T., Lin, C., Lin, H., & WU, J. M. (2012) · ISRN Urology · doi:10.5402/2012/272697 · Cited by 46
“We additionally tested if piceatannol affected S6 ribosomal protein levels and phosphorylation of p70-S6 kinase, both involved in control of cell proliferation, functioning as mTOR downstream targets [39, 40].”
BackgroundKim, S. H., Miller, F. R., Tait, L., Zheng, J., & Novak, R. F. (2009) · International Journal of Cancer · doi:10.1002/ijc.24278 · Cited by 42
Li, Y. D., Block, E., & Patel, J. (2002) · American Journal of Physiology - Lung cellular and Molecular Physiology · doi:10.1152/ajplung.00024.2002 · Cited by 42
“It is known that mTOR lies upstream of p70S6K and 4E-BP1 and that the TOR proteins are members of the PI3K superfamily that regulates cell growth and differentiation (1, 10, 33).”
BackgroundInfluentialLarsen, A.-K. R., Møller, M. T. N., Blankson, H., Samari, H. R., Holden, L., & Seglen, P. O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205028200 · Cited by 39
mTORC1 Is Involved in Hypoxia‐Induced Pulmonary Hypertension Through the Activation of Notch3
Wang, W., Liu, J., Ma, A.-P., Miao, R., Jin, Y., Zhang, H.-B., Xu, K.-F., Wang, C., & Wang, J. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24670 · Cited by 41
Lang, C. H. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00065.2006 · Cited by 39
“S6K1 is a Thr/Ser kinase that under some, but not all, conditions is associated with increased translation of mRNAs containing a terminal oligopyrimidine (TOP) tract downstream of their transcription initiation site (8).”
BackgroundTSC1-2 tumour suppressor and regulation of mTOR signalling: linking cell growth and proliferation?
Findlay, G. M., Harrington, L. S., & Lamb, R. F. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.11.002 · Cited by 40
Tang, X., Wang, L., Proud, C. G., & Downes, C. P. (2003) · Biochemical Journal · doi:10.1042/bj20021910 · Cited by 36
Ma, F.-L., Zhou, Z., Li, N., Zheng, L.-M., Wu, C., Niu, B., Tang, F., He, X., Li, G.-P., & Hua, J. (2016) · Scientific Reports · doi:10.1038/srep38805 · Cited by 40
Bagga, S., Rawat, S., Ajenjo, M., & Bouchard, M. J. (2016) · Virology · doi:10.1016/j.virol.2016.08.006 · Cited by 41
Targeting mTOR in cancer: renal cell is just a beginning
Azim, H. A., Azim, H. A., & Escudier, B. J. (2010) · Targeted Oncology · doi:10.1007/s11523-010-0141-x · Cited by 40
“The second downstream target is S6 kinase 1 (S6K1), which phosphorylates the 40S ribosomal protein S6. The later enhances the translation of mRNAs with a 5-terminal oligopyrimidine tract (TOP mRNAs), such as elongation factor-1 and ribosomal proteins (accounting for 15–20% of total cellular mRNA) [25, 26 ].”
BackgroundKatta, A., Karkala, S. K., Wu, M., Meduru, S., Desai, D. H., Rice, K. M., & Blough, E. R. (2009) · Muscle & Nerve · doi:10.1002/mus.21255 · Cited by 37
“Illustrating this fact is the finding that blockade of p70S6k activity results in significant inhibition of protein synthesis in multiple cell systems.(9,12,23,32,55) In skeletal muscle, the contractioninduced phosphorylation of p70S6K has been found to be elevated following HFES(1,36,37) and is highly correlated with…”
BackgroundSakakibara, K., Liu, B., Hollenbeck, S., & Kent, K. (2005) · American Journal of Physiology. Heart and Circulatory Physiology · doi:10.1152/ajpheart.00561.2004 · Cited by 39
“Selective inhibition of mitogen-induced mTOR-dependent activation of S6K by rapamycin impedes cell growth (4).”
BackgroundNemazanyy, I., Panasyuk, G., Zhyvoloup, A., Panayotou, G., Gout, I. T., & Filonenko, V. V. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.091 · Cited by 41
Giallourakis, C. C., Kashiwada, M., Pan, P., Danial, N. N., Jiang, H., Cambier, J. C., Coggeshall, K. M., & Rothman, P. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002853200 · Cited by 32
Otterhag, L., Gustavsson, N., Alsterfjord, M., Pical, C., Lehrach, H., Gobom, J., & Sommarin, M. (2006) · Biochimie · doi:10.1016/j.biochi.2005.07.005 · Cited by 39
“These targets, which include protein kinase B (PKB) isoforms, serum and glucocorticoid-inducible kinase (SGK), protein kinase C isoforms, p90 S6 kinase (S6K) and p70 ribosomal S6K, are involved in various physiological processes, including cell proliferation, differentiation and apoptosis [1–3].”
BackgroundEverolimus in the management of metastatic neuroendocrine tumours
Chan, D. L. H., Segelov, E., & Singh, S. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16674660 · Cited by 37
“1998] and cell growth [Dufner and Thomas, 1999].”
BackgroundJeong, W., Song, G., Bazer, F., & Kim, J. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.023 · Cited by 38
Diermeier‐Daucher, S., Breindl, S., Buchholz, S., Ortmann, O., & Brockhoff, G. (2011) · Cytometry Part A · doi:10.1002/cyto.a.21107 · Cited by 34
“Activation of mTOR and p70 S6 kinase, two consecutive downstream signaling proteins of the PI3K/Akt pathway involved in cell growth (28), was reduced by ErbB receptorspecific treatment only in BT474 (Fig.”
BackgroundFrey, J. W., Farley, E. E., O’Neil, T. K., Burkholder, T. J., & Hornberger, T. A. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.04.025 · Cited by 37
β-Adrenergic agonists regulate Na-K-ATPase via p70S6k
Pesce, L. M., Comellas, A. P., & Sznajder, J. I. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00266.2002 · Cited by 37
Amino Acid Regulation of Gene Expression
Jefferson, L. S., & Kimball, S. R. (2001) · Journal of Nutrition · doi:10.1093/jn/131.9.2460s · Cited by 62
Slavik, J. M., Lim, D., Burakoff, S. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3201 · Cited by 46
Yang, J.-C., Liu, M., Huang, R., Zhao, L., Niu, Q.-J., Xu, Z.-J., Wei, J., Lei, X. G., & Sun, L. (2024) · Science Advances · doi:10.1126/sciadv.adj4122 · Cited by 45
Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18
Flegel, C., Vogel, F., Hofreuter, A., Wójcik, S., Schoeder, C. T., Kieć‐Kononowicz, K., Brockmeyer, N., Müller, C., Becker, C., Altmuller, J., et al. (2016) · Scientific Reports · doi:10.1038/srep32255 · Cited by 37
Yamaoka, I., Doi, M., Nakayama, M., Ozeki, A., Mochizuki, S., Sugahara, K., & Yoshizawa, F. (2006) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00333.2005 · Cited by 37
Involvement of the ERK1/2 MAPK pathway in insulin-induced S6K1 activation in avian cells
Duchêne, S., Cailleau-Audouin, E., Crochet, S., Duclos, M. J. M. J., Dupont, J., & Tesseraud, S. (2006) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2006.11.001 · Cited by 44
Vahsen, B. F., Ribas, V. T., Sundermeyer, J., Boecker, A., Dambeck, V., Lenz, C., Shomroni, O., Gomes, L. C., Tatenhorst, L., Barski, E., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0543-y · Cited by 67
Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1
Choi, J., Yoon, Y., Kim, N., Park, C. S., Seol, H., Park, I., Kim, H.-A., Noh, W., Kim, J., & Seong, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-57496-8 · Cited by 36
Durbas, M., Horwacik, I., Boratyn, E., Kamycka, E., & Rokita, H. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3070 · Cited by 39
Soy peptide-induced stem cell proliferation: involvement of ERK and TGF-β1
Lee, J., Roh, K., Kim, S.-C., Lee, J., & Park, D. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.08.003 · Cited by 39
“Thus, mTOR/p70S6K is required for cell growth and cell cycle progression [5,6].”
BackgroundRegulation of S6 Kinase 1 Activation by Phosphorylation at Ser-411*
Hou, Z., He, L., & Qi, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607836200 · Cited by 36
di Prisco, M., Peruzzi, F., Belletti, B., & Baserga, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5447-5458.2001 · Cited by 31
“To confirm the effect of Id2 gene expression on differentiation, we have used a second approach, based on a previous paper, in which we showed that the mTOR-specific inhibitor, rapamycin (20), induces the differentiation of 32D IGF-IR/ IRS-1 cells (60).”
BackgroundMethodMolecular Mechanisms of Cardiac Hypertrophy Induced by Toxicants
Chen, Q. M., Tu, V. C., Purdom, S., Wood, J. R., & Dilley, T. (2001) · Cardiovascular Toxicology · doi:10.1385/ct:1:4:267 · Cited by 43
“Akt can activate p70 S6 kinase, which regulates protein translation and contributes to an increase of the protein content in hypertrophic cells (57,58).”
BackgroundInfluentialEverolimus – a new approach in the treatment of renal cell carcinoma
Eisen, T. G. (2010) · Cancer Management and Research · doi:10.2147/cmar.s6047 · Cited by 32
“Activation of S6K1 itself is also tightly regulated by hierarchical phosphorylation events, which are dependent on the activation of various signal transduction pathways and culminate in the phosphorylation of the rapamycin-sensitive site Thr389.”
Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma
Zhao, X., & Gartenhaus, R. (2009) · Expert opinion on therapeutic targets · doi:10.1517/14728220903103833 · Cited by 35
“In response to insulin, nutrients and growth factors, p70S6K is activated through a complex network of signaling molecules [36,37].”
BackgroundFleckenstein, D., Dirks, W., Drexler, H., & Quentmeier, H. (2003) · Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis · doi:10.1016/s0145-2126(02)00325-9 · Cited by 35
“These mRNAs encode primarily ribosomal proteins and translational elongation factors whose increased expression is essential for cell growth and proliferation [3].”
BackgroundThe Ups and Downs of Metabolism during the Lifespan of a T Cell
Balyan, R., Gautam, N., & Gascoigne, N. R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217972 · Cited by 36
“mTOR regulates protein synthesis via multiple phosphorylation targets, including p70S6 kinase, a regulator of ribosome function, and 4E-BP1, an inhibitor of translation [50].”
BackgroundXu, X., Chen, Y., Fu, Q., Ni, D., Zhang, J., Li, X., & Lu, S. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1553167 · Cited by 37
Ferulic Acid Promotes Hypertrophic Growth of Fast Skeletal Muscle in Zebrafish Model
Wen, Y., & Ushio, H. (2017) · Nutrients · doi:10.3390/nu9101066 · Cited by 37
“Phosphorylated p70S6K then phosphorylates S6, the protein of the 40S ribosomal subunits [44].”
BackgroundBhardwaj, A., Ganesan, N., Tachibana, K., Rajapakshe, K., Albarracin, C. T., Gunaratne, P. H., Coarfa, C., & Bedrosian, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127678 · Cited by 34
Smith, G. S. T., Samborska, B., Hawley, S. P., Klaiman, J. M., Gillis, T. E., Jones, N., Boggs, J. M., & Harauz, G. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23166 · Cited by 32
Moon, J., & Nelson, B. (2001) · Journal of Immunology · doi:10.4049/jimmunol.167.5.2714 · Cited by 33
“mTOR promotes cell growth by inactivating 4E-BP1(PHAS), an inhibitor of the translation initiation factor eIF4E, while p70 kinase phosphorylates the S6 subunit of the 40S ribosome, thus promoting translation of growth-related mRNA species distinguished by a unique 5 terminal oligopyrimidine tract (25, 26).”
BackgroundEveraert, N., Swennen, Q., Coustard, S. M., Willemsen, H., Careghi, C., Buyse, J., Bruggeman, V., Decuypere, E., & Tesseraud, S. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509991735 · Cited by 33
Bianchi, N., Finotti, A., Ferracin, M., Lampronti, I., Zuccato, C., Breveglieri, G., Brognara, E., Fabbri, E., Borgatti, M., Negrini, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121567 · Cited by 32
“Notably, mTOR-C1 complex is involved in the phosphorylation of the mTOR substrates p70S6K [53–55] and, by acting on p70S6K, it facilitates ribosome biogenesis and translation elongation [56, 57].”
BackgroundMammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors
Komori, Y., Yada, K., Ohta, M., Uchida, H., Iwashita, Y., Fukuzawa, K., Kashima, K., Yokoyama, S., Inomata, M., & Kitano, S. (2014) · Journal of hepato-biliary-pancreatic sciences · doi:10.1002/jhbp.26 · Cited by 32
“S6K phosphorylates the S6 protein of the 40S ribosomal subunit, and participates in translating the 5′ oligopyrimidine tract mRNAs [30].”
BackgroundNakai, N., Kawano, F., Oke, Y., Nomura, S., Ohira, T., Fujita, R., & Ohira, Y. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0147-3 · Cited by 34
“Effects of static and cyclic stretch on phosphorylation of p70S6K and eEF2 Phosphorylation of p70S6K at the threonine 389 residue results in the maximal kinase activity ( Dufner and Thomas, 1999 ).”
BackgroundTzeng, T., Kong, L.-R., Chen, C., Shaw, C.-C., & Yang, C. (2009) · Plant and Cell Physiology · doi:10.1093/pcp/pcp114 · Cited by 34
“…the 40S ribosomal protein, S6 (rpS6), resulting in an increase of translation for mRNA transcripts with an oligopyrimidine tract at their transcriptional start site, known as the 5 ′ TOP mRNAs ( Levy et al. 1991 , Jefferies et al. 1994 , Dufner and Thomas 1999 , Ruvinsky and Meyuhas 2006 ).”
BackgroundWang, X.-Q., Sun, P., Go, L., Koti, V., Fliman, M., & Paller, A. S. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700469 · Cited by 30
“The mechanism of this novel effect of GM3 appears to involve ERK-independent activation of the 70 kDa ribosomal S6 (p70S6) kinase, a serine/threonine protein kinase that is known to stimulate cell proliferation and survival (Dufner and Thomas, 1999).”
BackgroundSchumacher, A., Velentza, A. V., Watterson, D., & Dresios, J. (2006) · Biochemistry · doi:10.1021/bi060413y · Cited by 32
“Phosphorylation of S6 is correlated with the regulation of protein synthesis (15-19).”
BackgroundDifferential control of the NIMA-related kinases, Nek6 and Nek7, by serum stimulation.
Minoguchi, S., Minoguchi, M., & Yoshimura, A. (2003) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/s0006-291x(03)00049-4 · Cited by 32
Koh, P. (2010) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x10008196 · Cited by 32
Han, H.-J., Li, M., Son, J., Seo, C., Song, S., Kwak, S., & Bae, H. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.07.011 · Cited by 31
Métayer-Coustard, S., Mameri, H., Seiliez, I., Crochet, S., Crépieux, P., Mercier, Y., Geraert, P., & Tesseraud, S. (2010) · Journal of NutriLife · doi:10.3945/jn.110.122663 · Cited by 31
“Cells were scraped in cap column buffer (23) [4 mL of cap column buffer 53 (100 mmol/L HEPES, 0.”
MethodLang, C. H., Pruznak, A. M., & Frost, R. A. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20311 · Cited by 31
“This activation appears to play a role in the translational regulation of the mRNA family that encodes proteins containing a terminal oligopyrimidine tract downstream of their transcription initiation site [Dufner and Thomas, 1999].”
BackgroundJoo, E., Broxmeyer, H., Kwon, H.-J., Kang, H., Kim, J. S., Lim, J. S., Choe, Y., Choe, I., Myung, P., & Lee, Y. (2004) · Stem Cells and Development · doi:10.1089/scd.2004.13.563 · Cited by 31
“Whereas Bad is a pro-apoptotic protein, CREB is known to be a transcription factor involved in survival (5,8). p70/85S6K is known involved in translational control, and it is presumed to be regulated by PI3K/Akt pathway via mTOR (mammalian target of Rapamycin) (35).”
In vivo ethanol decreases phosphorylated MAPK and p70S6 kinase in the developing rat brain.
Tsuji, R., Guizzetti, M., & Costa, L. (2003) · NeuroReport · doi:10.1097/00001756-200307180-00023 · Cited by 31
Miyamoto, S., Kimball, S., & Safer, B. (2000) · Biochimica et Biophysica Acta · doi:10.1016/s0167-4781(00)00208-6 · Cited by 31
Damjanac, M., Page, G., Ragot, S., Laborie, G., Gil, R., Hugon, J., & Paccalin, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00688.x · Cited by 31
“1824 also another translation effector protein: p70S6K (p70 ribosomal S6 kinase) [13].”
BackgroundWang, R., Bhattacharya, R., Ye, X., Fan, F., Boulbés, D. R., & Ellis, L. M. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0341 · Cited by 34
“Compared with CM from colorectal cancer cells, CM from LPECs increased phosphorylation of AKT and several downstream targets of AKT [P70 (15) and S6 (16) kinases, eIF4B (17), and eEF2K (18)] in colorectal cancer cells (Fig.”
BackgroundHypoxia as a target for drug combination therapy of liver cancer
Bowyer, C. J., Lewis, A. L., Lloyd, A. W., Phillips, G. J., & Macfarlane, W. M. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000516 · Cited by 35
Arechiga, A. F., Bell, B. D., Leverrier, S., Weist, B. M., Porter, M. B., Wu, Z., Kanno, Y., Ramos, S. J., Ong, S. T., Siegel, R. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5291 · Cited by 31
“S6 is sequentially phosphorylated, with initial phosphorylation detected at serines 235 and 236, followed by subsequent phosphorylation at serines 240, 244, and 247 (40).”
BackgroundSeo, J., Lee, J.-H., Kim, N., Kim, Y., Chang, S.-H., Ko, N.-Y., Her, E., Yoo, Y., Kim, J.-W., Lee, B., et al. (2005) · The Journal of pharmacy and pharmacology · doi:10.1211/0022357056497 · Cited by 30
“…is widely acknowledged that p70 S6 kinase is activated through multiple phosphorylations and that its activation is critical for translation (Dunfer & Thomas 1997; Pullen & Thomas 1997). p70 S6 kinase was time-dependently activated by LPS, and after a 1-h stimulation, it showed maximal…”
BackgroundDamjanac, M., Rioux Bilan, A., Paccalin, M., Pontcharraud, R., Fauconneau, B., Hugon, J., & Page, G. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.09.008 · Cited by 32
Sukhija, N., Malik, A. A., Devadasan, M. J., Dash, A., Bidyalaxmi, K., Kumar, D. R., Devi, M. K., Choudhary, A., Kanaka, K. K., Sharma, R., et al. (2023) · Animal Biotechnology · doi:10.1080/10495398.2023.2290521 · Cited by 33
Temporal phases of long-term potentiation (LTP): myth or fact?
Abbas, A.-K., Villers, A., & Ris, L. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0072 · Cited by 31
Li, X.-Q., Choi, W. W., Yan, R., Yu, H., Krasnoperov, V., Kumar, S. R., Schuckman, A., Klumpp, D., Pan, C., Quinn, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105326 · Cited by 29
“For example, activated or phosphorylated S6 ribosomal protein which is downstream of PI3K-Akt [31] was markedly inhibited with sEphB4-HSA treatment.”
BackgroundJeong, W., Kim, J., Bazer, F. W., & Song, G. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.115873 · Cited by 28
“The primary downstream target of p70RSK is the 40S ribosomal protein S6 (RPS6), which is a major regulatory component of the protein synthetic machinery in mammalian cells [55, 56].”
BackgroundMapping Molecular Memory: Navigating the Cellular Pathways of Learning
Owen, G. R., & Brenner, E. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9836-0 · Cited by 26
Vender, J. R., Sukumari‐Ramesh, S., Singh, N., & Dhandapani, K. M. (2011) · Surgical Neurology International · doi:10.4103/2152-7806.77029 · Cited by 25
“Mammalian target of rapamycin (mTOR), a serine/ threonine kinase involved in diverse cellular processes, including protein translation, mRNA turnover, and protein stability, mediates, at least in part, some of the biological actions of Akt.[2,3,11] Based on our recent demonstration that basal Akt activation increased…”
BackgroundIshiguro, H., Katano, Y., Nakano, I., Ishigami, M., Hayashi, K., Honda, T., Goto, H., Bajotto, G., Maeda, K., & Shimomura, Y. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.02.037 · Cited by 31
Narita, M., Akai, H., Kita, T., Nagumo, Y., Narita, M., Sunagawa, N., Hara, C., Hasebe, K., Nagase, H., & Suzuki, T. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.050 · Cited by 31
Drosophilap53-related protein kinase is required for PI3K/TOR pathway-dependent growth
Ibar, C., Cataldo, V. F., Vásquez-Doorman, C., Olguı́n, P., & Glavic, Á. (2013) · Development · doi:10.1242/dev.086918 · Cited by 24
“…(phosphatidylinositol-3-kinase/Target Of Rapamycin, PI3K/TOR) play important roles in organ and cell growth controlling protein and lipid biosynthesis (Saltiel and Kahn, 2001; Efstratiadis, 1998; Leevers et al., 1996; Weinkove et al., 1999; van Sluijters et al., 2000; Dufner and Thomas, 1999).”
BackgroundZhang, B., & Fenton, R. G. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10148 · Cited by 24
“The activation of p70S6k is complex, with multiple sites of phosphorylation within the activation loop and regulatory domains required for its full activity (Weng et al., 1998; Dufner and Thomas, 1999).”
BackgroundZhang, H., Hoff, H. B., Marinucci, T., Cristofalo, V. J., & Sell, C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4965 · Cited by 29
Smith, W. A., & Rybczynski, R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-384749-2.10001-9 · Cited by 86
Metadata
- Authors
- Dufner, A., & Thomas, G.
- Affiliations
- Friedrich Miescher Institute (CH)
- Corresponding author
- Thomas, George
- ORCID
- Dufner, Almut
- Venue
- Experimental Cell Research
- Publisher
- Elsevier BV
- Published
- 1999-11
- Volume
- 253
- Issue
- 1
- Pages
- 100-109
- ISSN
- 0014-4827 (ISSN-L)
- OpenAlex
- W1963723155
- Cited by
- 676
- References
- 0
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 11 · 2021: 20 · 2020: 9 · 2019: 9 · 2018: 13 · 2017: 22 · 2016: 20 · 2015: 24 · 2014: 21 · 2013: 20 · 2012: 28
- FWCI
- 14.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Cell Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- RSK, S6K1, S6K2, translational regulation, PI3K signaling, PDK1, mTOR, kinase activation, activation loop, ribosome biogenesis, cell growth regulation, amino acid availability
- MeSH terms
- Cell Division, Enzyme Activation, Isoenzymes, Protein Kinase C, Protein Biosynthesis, Signal Transduction, Ribosomal Protein S6 Kinases, Sirolimus, Cell Size
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review